LivingGLP1
Study S000316

Efficacy of Treatment Strategies for Steroid-induced Diabetes - a Comparison of GLP-1 Receptor Agonist Plus Basal Insulin With Intensive Insulin Therapy

Registration

Registration
NCT07117240
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
ENROLLING_BY_INVITATION
Enrollment
100
Start
2025-07-10
Primary completion
2028-02-09
Lead sponsor
Medical University of Warsaw
Conditions
Steroid-Induced Diabetes; Steroid-Induced Hyperglycemia; Diabetes
Interventions
DRUG:lixisenatide + glargine; DRUG:Intensive insulin therapy
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Glucose monitoring index and Time in range [From enrollment to 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.